Difference between revisions of "Team:SYSU-MEDICINE/HP/Silver"

Line 348: Line 348:
 
         <h2>Ethics</h2>
 
         <h2>Ethics</h2>
 
         <p>
 
         <p>
             This is a project about treatment, which will be used on human beings finally.  The ethic issue of our project contains three parts. Firstly, after we carried out an interview with doctors and patients, we found out there were some ethic issues between researchers and patients.  Secondly, we searched information of animal welfare and learnt how to construct animal models because we will test our product on mice model. At last, we had a discussion about primate experiments. More链接到伦理部分<br/>
+
             This is a project about treatment, which will be used on human beings finally.  The ethic issue of our project contains three parts. Firstly, after we carried out an interview with doctors and patients, we found out there were some ethic issues between researchers and patients.  Secondly, we searched information of animal welfare and learnt how to construct animal models because we will test our product on mice model. At last, we had a discussion about primate experiments. <a target="_blank" href="https://2016.igem.org/Team:SYSU-MEDICINE/Ethics">More</a><br/>
 
             <br/>
 
             <br/>
 
         </p>
 
         </p>
 
         <h2>Laws and Legislation</h2>
 
         <h2>Laws and Legislation</h2>
 
         <p>
 
         <p>
             Laws and legislation are the vital factors of our product – MSCs preparation. During the research of clinical trials, we found that there is no MSCs drug in China although there exist about 10 MSCs drugs in the world. We thought laws and legislation are the breakthrough point. So laws of several different countries were analyzed to compare with that of China, aiming to find a proper way for development of MSCs therapy in China. More (Link to 6-4 Legislation) To know how far our project would go, we asked the secretory of Stem Cell Clinical Research Experts Committee if Conditional Approval is possible in China. More (Link to 6-2.4.3 Laws and Legislation on Stem Cell)<br/>
+
             Laws and legislation are the vital factors of our product – MSCs preparation. During the research of clinical trials, we found that there is no MSCs drug in China although there exist about 10 MSCs drugs in the world. We thought laws and legislation are the breakthrough point. So laws of several different countries were analyzed to compare with that of China, aiming to find a proper way for development of MSCs therapy in China.
 +
            <a target="_blank" href="https://2016.igem.org/Team:SYSU-MEDICINE/Legislation">More</a> To know how far our project would go, we asked the secretory of Stem Cell Clinical Research Experts Committee if Conditional Approval is possible in China.
 +
            <a target="_blank" href="https://2016.igem.org/Team:SYSU-MEDICINE/Interview#laws">More</a> <br/>
 
             <br/>
 
             <br/>
 
         </p>
 
         </p>
Line 359: Line 361:
 
         <p>
 
         <p>
 
             <br/>
 
             <br/>
             For general view, you can see our ‘safety page’ to have an overview of our investigation and discussion on safety. Second, there are two aspects that HP did during the project. One is the investigation of lab safety awareness of college students. More (Link to 6-9.3.1 Questionnaire Report 2 - The acknowledgment of biology safety  ) the other one is to make sure our product is safe for human use, we had researched on Quality Control of MSCs. More (Link to 6-2.4.2 Safety — Stem Cell Quality control)<br/>
+
             For general view, you can see our ‘safety page’ to have an overview of our investigation and discussion on safety. Second, there are two aspects that HP did during the project. One is the investigation of lab safety awareness of college students.
 +
            <a target="_blank" href="https://2016.igem.org/Team:SYSU-MEDICINE/Engagement#question2">More</a> the other one is to make sure our product is safe for human use, we had researched on Quality Control of MSCs.
 +
            <a target="_blank" href="https://2016.igem.org/Team:SYSU-MEDICINE/Interview#safe">More</a><br/>
 
             <br/>
 
             <br/>
  
Line 365: Line 369:
 
         <h2>Product analysis</h2>
 
         <h2>Product analysis</h2>
 
         <p>
 
         <p>
             At the very beginning, we thought it was so far away for our product to bring to the market that it seemed unnecessary to do the product analysis. A turning point appeared when we got to know Academician Wu’s research on a kind of MSCs drug, which encouraged us a lot and then we made a detailed product analysis including product contrastive analysis, cost analysis and intellectual property. More (Link to 6-5 Products) Additionally, we interviewed the chairman of DAAN Gene Company to know the attitude of biological company to our product. More (Link to 6-2.5 Interview DAAN Gene Company)<br/>
+
             At the very beginning, we thought it was so far away for our product to bring to the market that it seemed unnecessary to do the product analysis. A turning point appeared when we got to know Academician Wu’s research on a kind of MSCs drug, which encouraged us a lot and then we made a detailed product analysis including product contrastive analysis, cost analysis and intellectual property.
 +
            <a target="_blank" href="https://2016.igem.org/Team:SYSU-MEDICINE/Products">More</a> Additionally, we interviewed the chairman of DAAN Gene Company to know the attitude of biological company to our product.
 +
            <a target="_blank" href="https://2016.igem.org/Team:SYSU-MEDICINE/Interview#daan_gene">More</a><br/>
 
             <br/>
 
             <br/>
  
Line 372: Line 378:
 
         <p>
 
         <p>
 
             <br/>
 
             <br/>
             Most middle school students in China have rare chance to do biochemical experiments. All they can learn is only the theory. Students and teachers from middle school were invited attend an activity – “Have a Look at Your Genome”, which aims at sharing some basic knowledge of synthetic biology and sharing what we were doing with iGEM. More (Link to 6-9.2 Education) For benefit more high school students, we wrote a guidebook for the three experiments for high school teachers so that any high school can carry out these experiments for students. More (Link to 高中生那个手册Booklet)<br/>
+
             Most middle school students in China have rare chance to do biochemical experiments. All they can learn is only the theory. Students and teachers from middle school were invited attend an activity – “Have a Look at Your Genome”, which aims at sharing some basic knowledge of synthetic biology and sharing what we were doing with iGEM.
 +
            <a target="_blank" href="https://2016.igem.org/Team:SYSU-MEDICINE/Engagement#havealook">More</a> For benefit more high school students, we wrote a guidebook for the three experiments for high school teachers so that any high school can carry out these experiments for students.
 +
            <a target="_blank" href="https://2016.igem.org/Team:SYSU-MEDICINE/Engagement#brochure">More</a><br/>
 
             <br/>
 
             <br/>
             MSCs therapy is one of the hot research fields in resent years. However, it is little-known by the public. We held a lecture to help medical students to have a further understanding of MSCs and made a brochure introducing to the public. More (Link to 6-9.4 “MSC with GPS”)<br/>
+
             MSCs therapy is one of the hot research fields in resent years. However, it is little-known by the public. We held a lecture to help medical students to have a further understanding of MSCs and made a brochure introducing to the public.
 +
            <a target="_blank" href="https://2016.igem.org/Team:SYSU-MEDICINE/Engagement#gps">More</a><br/>
 
             <br/>
 
             <br/>
  
Line 383: Line 392:
 
         <p>
 
         <p>
 
             <br/>
 
             <br/>
             During the whole procedure of this project, for further understanding of our project, MSCs and our target audiences, we have done a lot of Human Practices work, though it remains a pity that we have not done a great job in some aspects. This summary contains what we think we could do better during the project. More Link to 6-1.3 Room for Improvement<br/>
+
             During the whole procedure of this project, for further understanding of our project, MSCs and our target audiences, we have done a lot of Human Practices work, though it remains a pity that we have not done a great job in some aspects. This summary contains what we think we could do better during the project.
 +
            <a target="_blank" href="https://2016.igem.org/Team:SYSU-MEDICINE/Our_Story#improvement">More</a><br/>
 
             <br/>
 
             <br/>
 
             <br/>
 
             <br/>

Revision as of 11:43, 19 October 2016

Silver

HP for Silver


During the project, HP devotes to study and investigate different aspects closely related to our project including ethics, law and legislation, safety, product analysis, even summary of room for improvement by the methods of literature studying, interview, questionnaire, attending Cell Therapy Annual Meeting etc. HP also had dialogue with high school students, college students and ordinary citizens.

Ethics

This is a project about treatment, which will be used on human beings finally. The ethic issue of our project contains three parts. Firstly, after we carried out an interview with doctors and patients, we found out there were some ethic issues between researchers and patients. Secondly, we searched information of animal welfare and learnt how to construct animal models because we will test our product on mice model. At last, we had a discussion about primate experiments. More

Laws and Legislation

Laws and legislation are the vital factors of our product – MSCs preparation. During the research of clinical trials, we found that there is no MSCs drug in China although there exist about 10 MSCs drugs in the world. We thought laws and legislation are the breakthrough point. So laws of several different countries were analyzed to compare with that of China, aiming to find a proper way for development of MSCs therapy in China. More To know how far our project would go, we asked the secretory of Stem Cell Clinical Research Experts Committee if Conditional Approval is possible in China. More

Safety


For general view, you can see our ‘safety page’ to have an overview of our investigation and discussion on safety. Second, there are two aspects that HP did during the project. One is the investigation of lab safety awareness of college students. More the other one is to make sure our product is safe for human use, we had researched on Quality Control of MSCs. More

Product analysis

At the very beginning, we thought it was so far away for our product to bring to the market that it seemed unnecessary to do the product analysis. A turning point appeared when we got to know Academician Wu’s research on a kind of MSCs drug, which encouraged us a lot and then we made a detailed product analysis including product contrastive analysis, cost analysis and intellectual property. More Additionally, we interviewed the chairman of DAAN Gene Company to know the attitude of biological company to our product. More

Education & Sustainability


Most middle school students in China have rare chance to do biochemical experiments. All they can learn is only the theory. Students and teachers from middle school were invited attend an activity – “Have a Look at Your Genome”, which aims at sharing some basic knowledge of synthetic biology and sharing what we were doing with iGEM. More For benefit more high school students, we wrote a guidebook for the three experiments for high school teachers so that any high school can carry out these experiments for students. More

MSCs therapy is one of the hot research fields in resent years. However, it is little-known by the public. We held a lecture to help medical students to have a further understanding of MSCs and made a brochure introducing to the public. More

Room for improvement


During the whole procedure of this project, for further understanding of our project, MSCs and our target audiences, we have done a lot of Human Practices work, though it remains a pity that we have not done a great job in some aspects. This summary contains what we think we could do better during the project. More